Cavinton · Evidence-based safety and harm-reduction overview.
| Also known as | Cavinton |
| Category | Nootropic |
| chemical_origin | Synthetic derivative of vincamine from Madagascar periwinkle |
| brand_name | Cavinton (Eastern Europe, Europe) |
| vascular_mechanism | Vasodilation and red blood cell deformability enhancement |
| US legal status | FDA has determined vinpocetine does not qualify as a dietary supplement under DSHEA. Sold in gray market; regulatory enforcement is inconsistent. |
Synthetic derivative of vinca alkaloid; proposed to enhance cerebral blood flow and vascular function. Vinpocetine is derived from vincamine alkaloid found in periwinkle plants and was modified for improved bioavailability and cerebrovascular selectivity.
Vinpocetine enhances cerebral microcirculation through vasodilation and improved red blood cell deformability. It also increases cerebral oxygen and glucose utilization, enhances ATP production, and provides neuroprotection through anti-inflammatory and antioxidant mechanisms.
Derived from vincamine, a vinca alkaloid from Madagascar periwinkle, in the 1970s by Hungarian researchers. Developed and marketed primarily in Eastern Europe as Cavinton. Gained some popularity in European cognitive decline research but never achieved FDA approval in the US.
Clinical trials from Europe and Eastern Europe, mostly 1990s-2000s; variable quality. Studies show modest effects on cognitive function and blood flow. Most evidence originates from Hungarian and other Eastern European research; Western replication minimal.
Clinical trials employed 10-30 mg daily, typically in divided doses. Standard pharmaceutical doses were 5-10 mg three times daily. Dietary supplement formulations range 5-30 mg per serving in available products.
This is general research/context information, not medical advice or a recommended protocol.
Historically combined with ginkgo biloba and other vasodilatory agents in European cognitive decline protocols, though controlled studies are absent. Sometimes stacked with choline sources for synergistic cholinergic and vascular support anecdotally.
Omega-3 fish oil (EPA and DHA). Well-studied dietary supplement with evidence for vascular and cognitive health; legal, regulated, and safer blood flow support.
See our recommended pickIf you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsFDA ruled it is not a qualifying dietary supplement, so supplements containing it face regulatory action. It remains sold online but status is legally ambiguous.
Vinpocetine has anticoagulant properties and may increase bleeding risk, especially combined with warfarin or other anticoagulants.
Cavinton is a brand name for pharmaceutical-grade vinpocetine marketed in Europe; formulation and purity are more controlled than gray-market products.
Clinical trials suggest benefits appear after 2-4 weeks of consistent use, with potential improvement continuing over months.
Some Eastern European research explores vinpocetine for post-stroke cognitive recovery; evidence is preliminary and not established in Western medicine.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.